A single-dose Covid vaccine made by Janssen has been approved for use in the UK by the medicines regulator.
The vaccine, which was 85% effective in stopping severe illness from Covid-19 in trials, has met expected safety standards.
Twenty million doses have been ordered for the UK, and will arrive later this year.
It will be the fourth vaccine to be used in the UK to protect against Covid-19.
More than 38 million people have now received a first dose of a vaccine in the UK - nearly three-quarters of the adult population.
The vaccine is likely to be used to give care home residents a booster jab ahead of winter because it can be easily stored and transported at fridge temperatures.
The UK's vaccine committee - the Joint Committee on Vaccination and Immunisation (JCVI) - will produce advice on exactly who should receive the Belgian-made vaccine in due course.
The single-dose jab has already been authorised by the European Medicines Agency (EMA), the Food and Drug Administration (FDA) in the US and the World Health Organization (WHO).
The US, South Africa and the European Union briefly paused the rollout of the vaccine in April - also known as Johnson & Johnson - after reports of rare blood clots.
https://news.google.com/__i/rss/rd/articles/CBMiKmh0dHBzOi8vd3d3LmJiYy5jby51ay9uZXdzL2hlYWx0aC01NzI4MzgzN9IBLmh0dHBzOi8vd3d3LmJiYy5jby51ay9uZXdzL2hlYWx0aC01NzI4MzgzNy5hbXA?oc=5
2021-05-28 11:42:56Z
52781628202610
Tidak ada komentar:
Posting Komentar